(Q39468230)

12 September 2017

title

Receptor for advanced glycation end products (RAGE) partially mediates HMGB1-ERKs activation in clear cell renal cell carcinoma (English)

1 reference

12 September 2017

Liguo Lin

1

1 reference

12 September 2017

Kaihua Zhong

2

1 reference

12 September 2017

Zhongkai Sun

3

1 reference

12 September 2017

Guozhong Wu

4

1 reference

12 September 2017

Guodong Ding

5

1 reference

12 September 2017

publication date

24 September 2011

1 reference

Journal of Cancer Research and Clinical Oncology

12 September 2017

published in

1 reference

12 September 2017

volume

138

1 reference

12 September 2017

issue

1

1 reference

12 September 2017

page(s)

11-22

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-011-1067-0

12 September 2017

exact match

0 references

cites work

Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer

1 reference

12 December 2020

Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases

1 reference

12 December 2020

HMGB1 as an autocrine stimulus in human T98G glioblastoma cells: role in cell growth and migration

1 reference

12 December 2020

HMGB1 and RAGE in inflammation and cancer

1 reference

12 December 2020

Current management of advanced and metastatic renal cell carcinoma.

1 reference

12 December 2020

Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer

1 reference

12 December 2020

The expression of receptor for advanced glycation end products is associated with angiogenesis in human oral squamous cell carcinoma

1 reference

12 December 2020

In vitro matrigel fibroblast invasion assay

1 reference

12 December 2020

S100B alters neuronal survival and dendrite extension via RAGE-mediated NF-κB signaling.

1 reference

12 December 2020

RAGE modulates hypoxia/reoxygenation injury in adult murine cardiomyocytes via JNK and GSK-3beta signaling pathways.

1 reference

12 December 2020

HMGB1 increases permeability of the endothelial cell monolayer via RAGE and Src family tyrosine kinase pathways

1 reference

12 December 2020

Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models

1 reference

12 December 2020

Cancer and Leukemia Group B Pathology Committee guidelines for tissue microarray construction representing multicenter prospective clinical trial tissues

1 reference

12 December 2020

RAGE expression in rhabdomyosarcoma cells results in myogenic differentiation and reduced proliferation, migration, invasiveness, and tumor growth.

1 reference

12 December 2020

HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma

1 reference

12 December 2020

1 reference

12 December 2020

The expression of HMGB1 protein and its receptor RAGE in human malignant tumors

1 reference

12 December 2020

Sphingosine 1-phosphate stimulates smooth muscle cell differentiation and proliferation by activating separate serum response factor co-factors

1 reference

12 December 2020

K-Ras and H-Ras activation promote distinct consequences on endometrial cell survival

1 reference

12 December 2020

Cardiovascular disease: what's all the AGE/RAGE about?

1 reference

12 December 2020

High-mobility group protein 1(Y): metastasis-associated or metastasis-inducing?

1 reference

12 December 2020

Immunohistochemical analysis of the S100A1, S100B, CD44 and Bcl-2 antigens and the rate of cell proliferation assessed by Ki-67 antibody in benign and malignant melanocytic tumours.

1 reference

12 December 2020

Expression of receptors for advanced glycosylation end products on renal cell carcinoma cells in vitro

1 reference

12 December 2020

TNM residual tumor classification revisited

1 reference

12 December 2020

Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation.

1 reference

12 December 2020

Non-histone nuclear factor HMGB1 as a therapeutic target in colorectal cancer

1 reference

12 December 2020

Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK.

1 reference

12 December 2020

The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival

1 reference

12 December 2020

Growth suppression and radiosensitivity increase by HMGB1 in breast cancer

1 reference

12 December 2020

Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up-regulation contribute to the onset of diabetic cardiomyopathy

1 reference

12 December 2020

RAGE signaling sustains inflammation and promotes tumor development

1 reference

12 December 2020

Regulated proteolysis of RAGE and AbetaPP as possible link between type 2 diabetes mellitus and Alzheimer's disease

1 reference

12 December 2020

Involvement of RAGE, NADPH oxidase, and Ras/Raf-1 pathway in glycated LDL-induced expression of heat shock factor-1 and plasminogen activator inhibitor-1 in vascular endothelial cells

1 reference

12 December 2020

[The alternative NF-kB activation pathway and cancer: friend or foe?].

1 reference

12 December 2020

Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications

1 reference

12 December 2020

Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer.

1 reference

12 December 2020

The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in viv

1 reference

12 December 2020

Renal cell carcinoma and proteomics

1 reference

12 December 2020

Management of metastatic renal cell carcinoma: current trends

1 reference

12 December 2020

Contemporary clinical epidemiology of renal cell carcinoma: insight from a population based case-control study

1 reference

12 December 2020

Prognostic significance of morphologic parameters in renal cell carcinoma

1 reference

12 December 2020

Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas

1 reference

12 December 2020

S100B protein stimulates microglia migration via RAGE-dependent up-regulation of chemokine expression and release

1 reference

12 December 2020

RAGE and RAGE ligands in cancer

1 reference

12 December 2020

Expression of receptor for advanced glycation end products and HMGB1/amphoterin in colorectal adenomas

1 reference

12 December 2020

The receptor RAGE: Bridging inflammation and cancer

1 reference

12 December 2020

Extracellular HMGB1 released by NMDA treatment confers neuronal apoptosis via RAGE-p38 MAPK/ERK signaling pathway

1 reference

12 December 2020

MK615 decreases RAGE expression and inhibits TAGE-induced proliferation in hepatocellular carcinoma cells

1 reference

12 December 2020

Introduction to NF-kappaB: players, pathways, perspectives

1 reference

12 December 2020

HMGB1 attenuates anti-metastatic defence of the liver in colorectal cancer.

1 reference

12 December 2020

10.1007/S00432-011-1067-0

Identifiers

DOI

1 reference

12 September 2017

1 reference